Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle-Reference-Cited by-同舟云学术

Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle

Published:2018-10-06 Issue:1 Volume:106 Page:148-163
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Bartelink Imke H.¹²³,Jones Ella F.⁴,Shahidi‐Latham Sheerin K.⁵,Lee Pei Rong Evelyn⁶,Zheng Yanan²,Vicini Paolo⁷,‘t Veer Laura⁶,Wolf Denise⁶,Iagaru Andrei⁸,Kroetz Deanna L.⁹,Prideaux Brendan¹⁰,Cilliers Cornelius¹¹,Thurber Greg M.¹¹,Wimana Zena¹²,Gebhart Geraldine¹²

Affiliation:

1. Department of MedicineUniversity of California, San Francisco San Francisco California USA

2. Clinical Pharmacology, Pharmacometrics and DMPK (CPD)MedImmune South San Francisco California USA

3. Department of Clinical Pharmacology and PharmacyAmsterdam UMCVrije Universiteit AmsterdamThe Netherlands

4. Department of Radiology and Biomedical ImagingUniversity of California, San Francisco San Francisco California USA

5. Drug Metabolism & PharmacokineticsGenentech South San Francisco California USA

6. Department of Laboratory Medicine of the UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco San Francisco California USA

7. Clinical Pharmacology, Pharmacometrics and DMPK (CPD)MedImmune Cambridge UK

8. Division of Nuclear Medicine and Molecular Imaging at Stanford Health Care Stanford California USA

9. Department of Bioengineering and Therapeutic Sciences (BTS)School of PharmacyUniversity of California, San Francisco San Francisco California USA

10. Rutgers New Jersey Medical SchoolPublic Health Research InstituteRutgers, The State University of New Jersey New Brunswick New Jersey USA

11. Departments of Chemical Engineering and Biomedical EngineeringUniversity of Michigan Ann Arbor Michigan USA

12. Institut Jules BordetUniversité Libre de Bruxelles (ULB) Brussels Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1211

Reference106 articles.

1. Precision Medicine Initiative. .

2. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

3. American Cancer Society Cancer Facts & Figures 2017. 1–182. (2017).

4. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

5. What Is the Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical Trials

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer;Expert Opinion on Drug Delivery;2024-01-29

2. Molecular View on the iRGD Peptide Binding Mechanism: Implications for Integrin Activity and Selectivity Profiles;Journal of Chemical Information and Modeling;2023-10-03

3. Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy;Scientific Reports;2023-08-02

4. Laser ablation‐inductively coupled plasma‐mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma;British Journal of Clinical Pharmacology;2023-07-14

5. 3D-imaging and quantitative assessment for size-related penetration of HfO2 nanoparticles in breast cancer tumor by synchrotron radiation microcomputed tomography;Analytica Chimica Acta;2023-07